Risk Management · Section 9.7
~6 min read · The Drug Safety Coach — Global PV Career Course
Key points
Full text
An additional risk minimisation measure, once implemented, doesn’t simply get assumed to be working — GVP Module XVI specifically governs how organisations are expected to evaluate whether their risk minimisation measures are actually achieving their intended effect, and this evaluation obligation is exactly why Lesson 9.4 described additional measures as things that need ongoing justification, not a one-time decision made and then left unexamined.
Effectiveness evaluation genuinely asks two separate questions, and conflating them is a common mistake. The first is a process question: is the measure actually being followed as designed — are prescribers completing the required certification, are patients actually receiving the educational materials, is the monitoring programme’s protocol being followed as specified. The second is an outcome question: even where the process is being followed correctly, is the underlying risk actually being reduced — is the adverse event rate measurably lower than it would be without the measure.
These two questions can genuinely diverge in either direction, which is exactly why both need independent measurement rather than assuming one implies the other. A measure can show excellent process compliance — every prescriber completes the mandatory training, every patient signs the required consent — while showing weak or negligible outcome effectiveness, because the training doesn’t actually change prescribing behaviour in the way intended, or because the underlying risk wasn’t as modifiable by education as assumed. Conversely, a measure with imperfect process compliance can still show meaningful outcome effectiveness if even partial adoption meaningfully shifts real-world risk.
The findings from this evaluation feed directly back into decisions about the measure itself and, more broadly, into the safety concern’s status in the RMP as a whole — a measure showing strong evidence of effectiveness continues, one showing weak evidence gets reconsidered or redesigned, and evaluation results across the full risk minimisation programme inform exactly the kind of addition, reclassification, or removal decisions covered in the next lesson on the safety concern lifecycle. Risk management, in this sense, closes its own loop the same way signal management did in Module 7 — evaluation isn’t an afterthought, it’s what keeps the whole system honest over time.
Quick check
Test yourself before moving on — no pressure, just click an answer.
1. Why does effectiveness evaluation of a risk minimisation measure need to assess both "process" and "outcome" separately, rather than just one?